CD8A and neoplasm: This upregulation of PD-L1 contributes to tumor progression by inhibiting effective T cell-mediated immune responses.264 Additionally, DKK1 upregulates PD-L1 in HCC through Akt/β-catenin signaling, decreasing CD8+ T cell infiltration and promoting tumor growth.265